Melanotan 2
Melanotan 2 appears in 307 indexed publications going back to 1992, including 16 in the past twelve months. 24 registered trials appear on ClinicalTrials.gov, 3 with Australian sites.
On This Figure
Overlaps with afamelanotide, the closely related approved analogue, which carries much of the clinical literature.
Publication history
How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.
Publications per year. The final bar is the current year, still in progress.
| 2015 | 18 |
|---|---|
| 2016 | 8 |
| 2017 | 11 |
| 2018 | 11 |
| 2019 | 3 |
| 2020 | 16 |
| 2021 | 22 |
| 2022 | 8 |
| 2023 | 16 |
| 2024 | 19 |
| 2025 | 12 |
| 2026 | 9 |
Who is looking it up
Monthly readers of the Melanotan 2 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.
The registered pipeline
3 trials have a registered Australian site.
Phase distribution across the most recently updated registered trials.
- Completed·Phase 1
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria Patients
Clinuvel Europe Limited · completed 2024-10-28
- Recruiting·Phase 2
Hudson Biotech · estimated completion 2027-02-14
- Active, not recruiting·Phase 3
Clinuvel, Inc. · completed 2025-12
- Completed·Phase 2
Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Variegate Porphyria (VP)
Clinuvel Pharmaceuticals Limited · completed 2023-12-28
- Completed·Phase 2
Clinuvel Pharmaceuticals Limited · completed 2016-02-02
- Status unknown·Phase 2
Clinuvel Europe Limited · completed 2024-06
Most recent work
The newest indexed records mentioning Melanotan 2, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.
- 2026-04-16·Journal of controlled release : official journal of the Controlled Release Society
Anderson CF, Wang X, Schneider JP. et al.
- 2026-01-14·Journal of pharmaceutical and biomedical analysis
Chawathe A, Sharma N. et al.
- 2026-03-01·Expert opinion on pharmacotherapy
Barman-Aksözen J, Granata F, Wäscher S et al.
- 2026-03-06·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Seidl-Philipp M, Schratter H, Auer J et al.
- 2026-03-02·Photochemistry and photobiology
Shetty N, Quiñonez RL, Ceresnie MS et al.
- 2026-02-03·Life (Basel, Switzerland)
Changes in Oral Mucosa Associated with Melanotan II Injections: A Case Report
Bonchev A. et al.
- 2026-02-16·Reports (MDPI)
Peshin S, Takrori E, Khan KS et al.
- 2025-11-24·JAAD case reports
Minder AE, Barman-Aksözen J. et al.
Melanotan 2 available from Polaris Research
Supplied as research materials for laboratory use. Free express delivery Australia wide.
Sources
Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.